Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cabergoline
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cabergoline 500microgram tablets
0607010C0AAAAAA
|
Cabergoline (Lactation) | Cabergoline | Endocrine System | 24,577 |
|
Dostinex 500microgram tablets
0607010C0BBAAAA
|
Dostinex | Cabergoline | Endocrine System | 2,218 |
|
Cabergoline 1mg tablets
0409010U0AAAAAA
|
Cabergoline (Parkinsonism) | Cabergoline | Central Nervous System | 1,567 |
|
Cabergoline 2mg tablets
0409010U0AAABAB
|
Cabergoline (Parkinsonism) | Cabergoline | Central Nervous System | 291 |
|
Cabaser 1mg tablets
0409010U0BBAAAA
|
Cabaser | Cabergoline | Central Nervous System | 9 |
|
Cabaser 2mg tablets
0409010U0BBABAB
|
Cabaser | Cabergoline | Central Nervous System | 4 |
|
Cabaser 4mg tablets
0409010U0BBACAC
|
Cabaser | Cabergoline | Central Nervous System | No data available |
|
Cabergoline 4mg tablets
0409010U0AAACAC
|
Cabergoline (Parkinsonism) | Cabergoline | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.